Identification of the cellular and molecular mechanisms that regulate bone remodelling is crucial for the development of effective skeletal therapeutics. A new study in mice shows that erythropoietin increases bone loss by enhancing osteoclast differentiation and bone resorption.
- Yusuke Shiozawa
- Russell S. Taichman
